» Articles » PMID: 3875380

Evidence That the Accumulation of 5-hydroxytryptamine in the Liver but Not in the Brain May Cause the Hypoglycaemia Induced by 5-hydroxytryptophan

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 1985 Jul 1
PMID 3875380
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Experiments were undertaken to determine whether the site of the hypoglycaemic action of 5-hydroxytryptophan (5-HTP), a direct precursor of 5-hydroxytryptamine (5-HT), was in the central nervous system or in the liver. The fall in blood glucose followed the rapid increase in the amount of 5-HT both in the brain and liver after 5-HTP injection into pargyline-treated and non-treated mice. Carbidopa, an inhibitor of peripheral aromatic amino acid decarboxylase, prevented the elevation of 5-HT levels in the liver of both pargyline-treated and non-treated mice. In contrast, carbidopa did not prevent but rather enhanced the elevation of 5-HT levels in the brain of both groups of mice. Corresponding to the prevention of 5-HT elevation in the liver, the fall in blood glucose was prevented by carbidopa. These results support the idea that the accumulation of 5-HT in the liver but not in the brain causes the hypoglycaemia induced by 5-HTP.

Citing Articles

Metabolomics Panel Associated with Cystic Fibrosis-Related Diabetes toward Biomarker Discovery.

Mujammami M, Nimer R, Al Mogren M, AlMalki R, Alabdaljabar M, Benabdelkamel H ACS Omega. 2024; 9(30):32873-32880.

PMID: 39100315 PMC: 11292812. DOI: 10.1021/acsomega.4c03626.


5-Hydroxytryptophan (5-HTP): Natural Occurrence, Analysis, Biosynthesis, Biotechnology, Physiology and Toxicology.

Maffei M Int J Mol Sci. 2020; 22(1).

PMID: 33375373 PMC: 7796270. DOI: 10.3390/ijms22010181.


Insulin sensitivity and premenstrual syndrome.

Trout K, Teff K Curr Diab Rep. 2004; 4(4):273-80.

PMID: 15265470 DOI: 10.1007/s11892-004-0079-4.


Primary role of interleukin-1 alpha and interleukin-1 beta in lipopolysaccharide-induced hypoglycemia in mice.

Oguri S, Motegi K, Iwakura Y, Endo Y Clin Diagn Lab Immunol. 2002; 9(6):1307-12.

PMID: 12414765 PMC: 130127. DOI: 10.1128/cdli.9.6.1307-1312.2002.


Suppression and potentiation of 5-hydroxytryptophan-induced hypoglycaemia by alpha-monofluoromethyldopa: correlation with the accumulation of 5-hydroxytryptamine in the liver.

Endo Y Br J Pharmacol. 1987; 90(1):161-5.

PMID: 3493049 PMC: 1917283. DOI: 10.1111/j.1476-5381.1987.tb16836.x.

References
1.
Lundquist I, EKHOLM R, Ericson L . Monoamines in the pancreatic islets of the mouse. 5-hydroxytryptamine as an intracellular modifier of insulin secretion, and the hypoglycaemic action of monoamine oxidase inhibitors. Diabetologia. 1971; 7(6):414-22. DOI: 10.1007/BF01212056. View

2.
RAY P, Hanson R, LARDY H . Inhibition by hydrazine of gluconeogenesis in the rat. J Biol Chem. 1970; 245(4):690-6. View

3.
Filkins J, Cornell R . Depression of hepatic gluconeogenesis and the hypoglycemia of endotoxin shock. Am J Physiol. 1974; 227(4):778-81. DOI: 10.1152/ajplegacy.1974.227.4.778. View

4.
Darwish S, Furman B . Medication of the hypoglycaemic effect of 5-hydroxytryptophan by a central nervous system action. Experientia. 1974; 30(11):1306-7. DOI: 10.1007/BF01945199. View

5.
Furman B . The hypoglycaemic effect of 5-hydroxytryptophan. Br J Pharmacol. 1974; 50(4):575-80. PMC: 1776716. DOI: 10.1111/j.1476-5381.1974.tb08591.x. View